03/18/2010 05:12 am ET | Updated May 25, 2011

Big Pharma Deal May Be Cut Back By Last-Minute Progressive Resistance

Facing last-minute liberal resistance in Congress, the drug industry is bracing for an increase in its share of the cost of the proposed health care overhaul beyond the $80 billion over 10 years that it had negotiated with the White House, industry lobbyists say.

House lawmakers and Senate liberals were furious to learn in August that to win drug makers' political support, the White House and the Senate Finance Committee had struck the deal to cap industry costs at $80 billion. But the White House and the Senate nonetheless appeared to stick by the agreement, which drug lobbyists called "rock-solid."

Read more on New York Times

Subscribe to the Politics email.
How will Trump’s administration impact you?